Santos C, Azuara D, Vieitez JM, Paez D, Falco E, Elez E, Lopez-Lopez C, Valladares M, Robles-Diaz L, Garcia-Alfonso P, Buges C, Duran G, Salud A, Navarro V, Capella G, Salazar R, Aranda E (2019).
Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial.
ANNALS OF ONCOLOGY. Article. 30(5):796-803.
[doi:10.1093/annonc/mdz082]
Melisi, D, Garcia-Carbonero, R, Macarulla, T, Pezet, D, Deplanque, G, Fuchs, M, Trojan, J, Kozloff, M, Simionato, F, Cleverly, A, Smith, C, Wang, S, Man, M, Driscoll, KE, Estrem, ST, Lahn MMF, Benhadji, KA, Tabernero, J (2019).
TGFbeta receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer.
CANCER CHEMOTHERAPY AND PHARMACOLOGY. Article. 83(5):975-991.
[doi:10.1007/s00280-019-03807-4]
Perea, J, Garcia, JL, Corchete, L, Lumbreras, E, Arriba, M, Rueda, D, Tapial, S, Perez, J, Vieiro, V, Rodriguez, Y, Brandariz, L, Garcia-Arranz, M, Garcia-Olmo, D, Goel, A, Urioste, M, Sarmiento, RG (2019).
Redefining synchronous colorectal cancers based on tumor clonality
INTERNATIONAL JOURNAL OF CANCER. Article. 144(7):1596-1608.
[doi:10.1002/ijc.31761]
Vidal, J, Bellosillo, B, Santos Vivas C, Garcia-Alfonso, P, Carrato, A, Cano, MT, Garcia-Carbonero, R, Elez, E, Losa, F, Massuti, B, Valladares-Ayerbes, M, Vieitez, JM, Manzano, JL, Azuara, D, Gallego, J, Pairet, S, Capella, G, Salazar, R, Tabernero, J, Aranda, E, Montagut, C (2019).
Ultra-selection of metastatic colorectal cancer patients using next-generation sequencing to improve clinical efficacy of anti-EGFR therapy.
ANNALS OF ONCOLOGY. Article. 30(3):439-446.
[doi:10.1093/annonc/mdz005]
Grande, E, Diaz, A, Lopez, C, Munarriz, J, Reina, JJ, Vera, R, Bernardez, B, Aller, J, Capdevila, J, Garcia-Carbonero, R, Jimenez Fonseca P, Trapero-Bertran, M (2019).
Economics of gastroenteropancreatic neuroendocrine tumors: a systematic review
Therapeutic Advances In Endocrinology And Metabolism. Review. 10.
[doi:10.1177/2042018819828217]
Alvaro, E, Cano, JM, Garcia, JL, Brandariz, L, Olmedillas-Lopez, S, Arriba, M, Rueda, D, Rodriguez, Y, Canete, A, Arribas, J, Inglada-Perez, L, Perez, J, Gomez, C, Garcia-Arranz, M, Garcia-Olmo, D, Goel, A, Urioste, M, Gonzalez-Sarmiento, R, Perea, J (2019).
Clinical and Molecular Comparative Study of Colorectal Cancer Based on Age-of-Onset and Tumor Location: Two Main Criteria for Subclassifying Colorectal Cancer
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Article. 20(4).
[doi:10.3390/ijms20040968]
Gonzalez-Granado, LI, Ruiz-Garcia, R, Blas-Espada, J, Moreno-Villares, JM, German-Diaz, M, Lopez-Nevado, M, Paz-Artal, E, Toldos, O, Rodriguez-Gil, Y, de Inocencio, J, Dominguez-Pinilla, N, Allende, LM (2019).
Acquired and Innate Immunity Impairment and Severe Disseminated Mycobacterium genavense Infection in a Patient With a NF-kappa B1 Deficiency
Frontiers in immunology. Article. 9:3148-3148.
[doi:10.3389/fimmu.2018.03148]
La Salvia, A, Lopez-Gomez, V, Garcia-Carbonero, R (2019).
HER2-targeted therapy: an emerging strategy in advanced colorectal cancer
EXPERT OPINION ON INVESTIGATIONAL DRUGS. Article. 28(1):29-38.
[doi:10.1080/13543784.2019.1555583]
Baudin, E, Hayes, AR, Scoazec, JY, Filosso, PL, Lim, E, Kaltsas, G, Frilling, A, Chen, J, Kos-Kudla, B, Gorbunova, V, Wiedenmann, B, van Dijkum, EN, Cwikla, JB, Falkerby, J, Valle, JW, Kulke, MH, Caplin, ME, Detlef, B, Rudolf, A, Eric, B, Lisa, B, Ivan, B, Jaume, C, Martyn, C, Jie, C, Frederico, C, Anne, C, Jaroslaw, BC, Philippa, D, de Herder, WW, Massimo, F, Jenny, F, Nicola, F, Diego, F, Andrea, F, Rocio, GC, Simona, G, Vera, G, Ashley, G, Dieter, H, Robert, J, Gregory, K, Gunter, K, Peter, KU, Beata, KK, Guenter, JK, Eric, K, Matthew, K, Steven, WJL, Elisabeth, NV, Manuel, OJ, Dermot, O, Ulrich-Frank, P, Stefano, P, Ellen, PM, Marc, P, John, R, Simon, RN, Guido, R, Anja, R, Philippe, R, Halfdan, S, Anders, S, Jean-Yves, S, Babs, GT, Eva, TJ, Christos, T, Juan, V, Marie-Pierre, V, Staffan, W, Bertram, W, ENETS 2016 Munich Advisory Board (2019).
Unmet Medical Needs in Pulmonary Neuroendocrine (Carcinoid) Neoplasms
NEUROENDOCRINOLOGY. Article. 108(1):7-17.
[doi:10.1159/000493980]
Ramage, JK, Valle, JW, Dijkum, EJMN, Sundin, A, Pascher, A, Couvelard, A, Kloeppel, G, Bartsch, D, Arnold, R, Baudin, E, Bodei, L, Borbath, I, Capdevila, J, Caplin, M, Chen, J, Costa, F, Couvelard, A, Cwikla, JB, Davies, P, de Herder, WW, Falconi, M, Falkerby, J, Fazio, N, Ferone, D, Frilling, A, Garcia-Carbonero, R, Glasberg, S, Gorbunova, V, Grossman, A, Horsch, D, Jensen, R, Kaltsas, G, Kloppel, G, Kingge, UP, Kos-Kudla, B, Krejs, GJ, Krenning, E, Kulke, M, Lamberts, SWJ, van Dijkum, EJMN, O'Connor, JM, O'Toole, D, Pape, UF, Partelli, S, Pavel, ME, Peeters, M, Ramage, JK, Reed, NS, Rindi, G, Rinke, A, Ruszniewski, P, Sorbye, H, Sundin, A, Scoazec, JY, Taal, BG, Janson, ET, Toumpanakis, C, Valle, JW, Vullierme, MP, Staffan, W, Wiedenmann, B, ENETS 2016 Munich Advisory Board (2019).
Colorectal Neuroendocrine Neoplasms: Areas of Unmet Need
NEUROENDOCRINOLOGY. Article. 108(1):45-53.
[doi:10.1159/000493767]
Toumpanakis, C, Fazio, N, Janson, ET, Horsch, D, Pascher, A, Reed, N, O'Toole, D, Dijkum, EN, Partelli, S, Rinke, A, Kos-Kudla, B, Costa, F, Pape, UF, Grozinsky-Glasberg, S, Scoazec, JY, Detlef, B, Rudolf, A, Eric, B, Lisa, B, Ivan, B, Jaume, C, Martyn, C, Jie, C, Frederico, C, Anne, C, Jaroslaw, BC, de Herder, WW, Massimo, F, Jenny, F, Nicola, F, Diego, F, Andrea, F, Rocio, GC, Simona, G, Vera, G, Ashley, G, Dieter, H, Robert, J, Gregory, K, Gunter, K, Peter, KU, Beata, KK, Guenter, JK, Eric, K, Matthew, K, Steven, WJL, Elisabeth, NV, Manuel, OJ, Dermot, O, Ulrich-Frank, P, Stefano, P, Ellen, PM, Marc, P, John, R, Nicholas, R, Guido, R, Anja, R, Philippe, R, Halfdan, S, Anders, S, Jean-Yves, S, Babs, GT, Eva, TJ, Christos, T, Juan, V, Marie-Pierre, V, Staffan, W, Bertram, W, ENETS 2016 Munich Advisory Board (2019).
Unmet Needs in Appendiceal Neuroendocrine Neoplasms
NEUROENDOCRINOLOGY. Article. 108(1):37-44.
[doi:10.1159/000493894]
Jensen, RT, Bodei, L, Capdevila, J, Couvelard, A, Falconi, M, Glasberg, S, Kloppel, G, Lamberts, S, Peeters, M, Rindi, G, Rinke, A, Rothmund, M, Sundin, A, Welin, S, Fazio, N, Rudolf, A, Detlef, B, Eric, B, Lisa, B, Ivan, B, Jaume, C, Martyn, C, Jie, C, Frederico, C, Anne, C, Jaroslaw, BC, Philippa, D, de Herder, WW, Massimo, F, Jenny, F, Nicola, F, Diego, F, Andrea, F, Rocio, GC, Simona, G, Vera, G, Ashley, G, Dieter, H, Robert, TJ, Gregory, K, Gunter, K, Peter, KU, Beata, KK, Guenter, JK, Eric, K, Steven, WJL, Elisabeth, NV, Manuel, OJ, Dermot, O, Ulrich-Frank, P, Stefano, P, Ellen, PM, Marc, P, John, R, Simon, RN, Guido, R, Anja, R, Philippe, R, Jean-Yves, S, Halfdan, S, Anders, S, Babs, GT, Eva, TJ, Christos, T, Juan, V, Marie-Pierre, V, Staffan, W, Bertram, W, ENETS 2016 Munich Advisory Board (2019).
Unmet Needs in Functional and Nonfunctional Pancreatic Neuroendocrine Neoplasms
NEUROENDOCRINOLOGY. Article. 108(1):26-36.
[doi:10.1159/000494258]
Capdevila, J, Bodei, L, Davies, P, Gorbounova, V, Jensen, RT, Knigge, UP, Krejs, GJ, Krenning, E, O'Connor, JM, Peeters, M, Rindi, G, Salazar, R, Vullierme, MP, Pavel, ME, Arnold, R, Bartsch, D, Baudin, E, Bodei, L, Borbath, I, Capdevila, J, Caplin, M, Chen, J, Costa, F, Couvelard, A, Cwikla, JB, Davies, P, de Herder, WW, Falconi, M, Falkerby, J, Fazio, N, Ferone, D, Frilling, A, Garcia-Carbonero, R, Glasberg, S, Gorbunova, V, Grossman, A, Horsch, D, Jensen, RT, Kaltsas, G, Kloppel, G, Knigge, UP, Kos-Kudla, B, Krejs, GJ, Krenning, E, Kulke, M, Lamberts, SWJ, van Dijkum, EN, O'Connor, JM, O'Toole, D, Pape, UF, Partelli, S, Pavel, ME, Peeters, M, Ramage, J, Reed, NSB, Rindi, G, Rinke, A, Ruszniewski, P, Sorbye, H, Sundin, A, Scoazec, JY, Taal, BG, Tiensuu, JE, Toumpanakis, C, Valle, J, Vullierme, MP, Welin, S, Wiedenmann, B, ENETS 2016 Munich Advisory Board (2019).
Unmet Medical Needs in Metastatic Lung and Digestive Neuroendocrine Neoplasms
NEUROENDOCRINOLOGY. Article. 108(1):18-25.
[doi:10.1159/000493319]
Sorbye H, Baudin E, Borbath I, Caplin M, Chen J, Cwikla JB, Frilling A, Grossman A, Kaltsas G, Scarpa A, Welin S, Garcia-Carbonero R, ENETS 2016 Munich Advisory Board Participants (2019).
Unmet Needs in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3)
NEUROENDOCRINOLOGY. Article. 108(1):54-62.
[doi:10.1159/000493318]
Mitjavila, M, Percovich, JC, Pasin, MCP, Bello, P, Arbizu, J, Llana, B, Riesco, MC, Muros, MA, Estenoz, J, Rotger, A, Aller, J, Jimenez-Fonseca, P (2019).
Patients with Advanced Neuroendocrine Tumors Treated with Peptide Receptor Radionuclide Therapy with 177Lu-DOTATE: Data from Spanish SEPTRALU Registry
NEUROENDOCRINOLOGY. Meeting Abstract. 108:223-223.
Jimenez-Fonseca, P, Alonso, V, Riesco, MC, Custodio, A, Molina-Cerrillo, J, Canovas, MS, Benavent, M, Cubero, JH, La Casta, A, Lopez, C, Azpiroz, MM, Carmona-Bayonas, A (2019).
Nomogram to Predict Progression-free Survival in Patients with Well-differentiated, Stage IV Gastroenteropancreatic Neuroendocrine Tumors Treated with Somatostatin Analogues: Data of TRASGU-GETNE Study
NEUROENDOCRINOLOGY. Meeting Abstract. 108:67-67.
Gonzalez-Flores E, Serrano R, Sevilla I, Viudez A, Barriuso J, Benavent M, Capdevila J, Jimenez-Fonseca P, Lopez C, Garcia-Carbonero R (2019).
SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2018)
CLINICAL & TRANSLATIONAL ONCOLOGY. Article. 21(1):55-63.
[doi:10.1007/s12094-018-1980-7]
Yoshino, T, Portnoy, DC, Obermannova, R, Bodoky, G, Prausova, J, Garcia-Carbonero, R, Ciuleanu, T, Garcia-Alfonso, P, Cohn, AL, Van Cutsem, E, Yamazaki, K, Lonardi, S, Muro, K, Kim, TW, Yamaguchi, K, Grothey, A, O'Connor, J, Taieb, J, Wijayawardana, SR, Hozak, RR, Nasroulah, F, Tabernero, J (2019).
Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III study
ANNALS OF ONCOLOGY. Article. 30(1):124-131.
[doi:10.1093/annonc/mdy461]
Capdevila J, Teulé A, Barriuso J, Castellano D, Lopez C, Manzano JL, Alonso V, García-Carbonero R, Dotor E, Matos I, Custodio A, Casanovas O, Salazar R, EVERLAR study investigators (2019).
Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR Study
ONCOLOGIST. Article. 24(1):38-46.
[doi:10.1634/theoncologist.2017-0622]
Fernandez, A, Salgado, M, Garcia, A, Buxo, E, Vera, R, Adeva, J, Jimenez-Fonseca, P, Quintero, G, Llorca, C, Canabate, M, Lopez, LJ, Munoz, A, Ramirez, P, Gonzalez, P, Lopez, C, Reboredo, M, Gallardo, E, Sanchez-Canovas, M, Gallego, J, Guillen, C, Ruiz-Miravet, N, Navarro-Perez, V, De la Camara, J, Ales-Diaz, I, Pazo-Cid, RA, Carmona-Bayonas, A (2018).
Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study
BMC CANCER. Article. 18(1):1185-1185.
[doi:10.1186/s12885-018-5101-3]
Melisi, D, Garcia-Carbonero, R, Macarulla, T, Pezet, D, Deplanque, G, Fuchs, M, Trojan, J, Oettle, H, Kozloff, M, Cleverly, A, Smith, C, Estrem, ST, Gueorguieva, I, Lahn MMF, Blunt, A, Benhadji, KA, Tabernero, J (2018).
Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer
BRITISH JOURNAL OF CANCER. Article. 119(10):1208-1214.
[doi:10.1038/s41416-018-0246-z]
Marin-Gabriel, JC, Lora-Pablos, D, Diaz-Tasende, J, Cancelas-Navia, P, Rodriguez-Munoz, S, del-Pozo-Garcia, AJ, Alonso-Riano, M, Rodriguez-Gil, Y, Ibarrola-Andres, C, Castellano-Tortajada, G (2018).
Switching from endoscopic submucosal dissection to salvage piecemeal knife-assisted snare resection to remove a lesion: a preoperative risk score from the beginning
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS. Article. 110(11):699-705.
[doi:10.17235/reed.2018.5608/2018]
Barriuso J, Custodio A, Afonso R, Alonso V, Astudillo A, Capdevila J, Garcia-Carbonero R, Grande E, Jimenez-Fonseca P, Marazuela M, Rodriguez-Antona C, Aller J (2018).
Prognostic and predictive biomarkers for somatostatin analogs, peptide receptor radionuclide therapy and serotonin pathway targets in neuroendocrine tumours
CANCER TREATMENT REVIEWS. Review. 70:209-222.
[doi:10.1016/j.ctrv.2018.09.008]
Damaso, E, Castillejo, A, Arias MDM, Canet-Hermida, J, Navarro, M, del Valle, J, Campos, O, Fernandez, A, Marin, F, Turchetti, D, Garcia-Diaz, JD, Lazaro, C, Genuardi, M, Rueda, D, Alonso, A, Soto, JL, Hitchins, M, Pineda, M, Capella, G (2018).
Primary constitutional MLH1 epimutations: a focal epigenetic event
BRITISH JOURNAL OF CANCER. Article. 119(8):978-987.
[doi:10.1038/s41416-018-0019-8]
Salvador-Martin, S, Garcia-Gonzalez, X, Garcia, MI, Blanco, C, Garcia-Alfonso, P, Robles, L, Gravalos, C, Pachon, V, Longo, F, Martinez, V, Sanjurjo-Saez, M, Lopez-Fernandez, LA (2018).
Clinical utility of ABCB1 for preventing toxicity in treatment with irinotecan
PHARMACOLOGICAL RESEARCH. Article. 136:133-139.
[doi:10.1016/j.phrs.2018.08.026]
Carril-Ajuria L, Jimenez-Aguilar E, Gomez-Martin C, Diaz-Pedroche C (2018).
An unsuspected complication with immune checkpoint blockade: a case report.
Journal Of Medical Case Reports. Article. 12(1):246-246.
[doi:10.1186/s13256-018-1782-0]
Diaz-Serrano, A, Angulo, B, Dominguez, C, Pazo-Cid, R, Salud, A, Jimenez-Fonseca, P, Leon, A, Galan, MC, Alsina, M, Rivera, F, Plaza, JC, Paz-Ares, L, Lopez-Rios, F, Gomez-Martin, C (2018).
Genomic Profiling of HER2-Positive Gastric Cancer: PI3K/Akt/mTOR Pathway as Predictor of Outcomes in HER2-Positive Advanced Gastric Cancer Treated with Trastuzumab
ONCOLOGIST. Article. 23(9):1092-1102.
[doi:10.1634/theoncologist.2017-0379]
Krauss T, Ferrara AM, Links TP, Wellner U, Bancos I, Kvachenyuk A, Villar Gomez de Las Heras K, Yukina MY, Petrov R, Bullivant G, von Duecker L, Jadhav S, Ploeckinger U, Welin S, Schalin-Jantti C, Gimm O, Pfeifer M, Ngeow J, Hasse-Lazar K, Sanso G, Qi X, Ugurlu MU, Diaz RE, Wohllk N, Peczkowska M, Aberle J, Lourenco DM Jr, Pereira MAA, Fragoso MCBV, Hoff AO, Almeida MQ, Violante AHD, Quidute ARP, Zhang Z, Recasens M, Diaz LR, Kunavisarut T, Wannachalee T, Sirinvaravong S, Jonasch E, Grozinsky-Glasberg S, Fraenkel M, Beltsevich D, Egorov VI, Bausch D, Schott M, Tiling N, Pennelli G, Zschiedrich S, Darr R, Ruf J, Denecke T, Link KH, Zovato S, von Dobschuetz E, Yaremchuk S, Amthauer H, Makay O, Patocs A, Walz MK, Huber TB, Seufert J, Hellman P, Kim RH, Kuchinskaya E, Schiavi F, Malinoc A, Reisch N, Jarzab B, Barontini M, Januszewicz A, Shah N, Young WF Jr, Opocher G, Eng C, Neumann HPH, Bausch B (2018).
Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors
ENDOCRINE-RELATED CANCER. Article. 25(9):783-793.
[doi:10.1530/ERC-18-0100]
Pena-Couso, L, Perea, J, Melo, S, Mercadillo, F, Figueiredo, J, Sanches, JM, Sanchez-Ruiz, A, Robles, L, Seruca, R, Urioste, M (2018).
Clinical and functional characterization of the CDH1 germline variant c.1679C > G in three unrelated families with hereditary diffuse gastric cancer
EUROPEAN JOURNAL OF HUMAN GENETICS. Article. 26(9):1348-1353.
[doi:10.1038/s41431-018-0173-8]
Herrera, M, Llorens, C, Rodriguez, M, Herrera, A, Ramos, R, Gil, B, Candia, A, Larriba, MJ, Garre, P, Earl, J, Rodriguez-Garrote, M, Caldes, T, Bonilla, F, Carrato, A, Garcia-Barberan, V, Pena, C (2018).
Differential distribution and enrichment of non-coding RNAs in exosomes from normal and Cancer-associated fibroblasts in colorectal cancer
MOLECULAR CANCER. Article. 17(1):114-114.
[doi:10.1186/s12943-018-0863-4]
Tesch, VK, IJspeert, H, Raicht, A, Rueda, D, Dominguez-Pinilla, N, Allende, LM, Colas, C, Rosenbaum, T, Ilencikova, D, Baris, HN, Nathrath, MHM, Suerink, M, Januszkiewicz-Lewandowska, D, Ragab, I, Azizi, AA, Wenzel, SS, Zschocke, J, Schwinger, W, Kloor, M, Blattmann, C, Brugieres, L, van der Burg, M, Wimmer, K, Seidel, MG (2018).
No Overt Clinical Immunodeficiency Despite Immune Biological Abnormalities in Patients With Constitutional Mismatch Repair Deficiency
Frontiers in immunology. Article. 9:1506-1506.
[doi:10.3389/fimmu.2018.01506]
Salazar, R, Garcia-Carbonero, R, Libutti, SK, Hendifar, AE, Custodio, A, Guimbaud, R, Lombard-Bohas, C, Ricci, S, Klumpen, HJ, Capdevila, J, Reed, N, Walenkamp, A, Grande, E, Safina, S, Meyer, T, Kong, O, Salomon, H, Tavorath, R, Yao, JC (2018).
Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Naive Advanced Pancreatic Neuroendocrine Tumors
ONCOLOGIST. Article. 23(7):766.
[doi:10.1634/theoncologist.2017-0144]
Soriano-Ramos M, Salcedo Lobato E, Rodríguez Gil Y, Medina Benítez E, Urruzuno Tellería P (2018).
Hematemesis as debut of eosinophilic gastroenteritis in infants
ANALES DE PEDIATRIA. Letter. 88(6):351-353.
[doi:10.1016/j.anpedi.2017.09.003]
Martinez-Perez, J, Riesco-Martinez, MC, Garcia-Carbonero, R (2018).
The safety of trifluridine and tipiracil for the treatment of metastatic colorectal cancer
EXPERT OPINION ON DRUG SAFETY. Article. 17(6):643-650.
[doi:10.1080/14740338.2018.1475557]
Alvarez, R, Carrato, A, Adeva, J, Ales, I, Prados, S, Valladares, M, Macarulla, T, Munoz, A, Hidalgo, M (2018).
Management of hyperbilirubinaemia in pancreatic cancer patients
EUROPEAN JOURNAL OF CANCER. Review. 94:26-36.
[doi:10.1016/j.ejca.2018.01.078]
Nuñez-Valdovinos B, Carmona-Bayonas, A, Jimenez-Fonseca, P, Capdevila, J, Castaño-Pascual Á, Benavent, M, Pi Barrio JJ, Teule, A, Alonso, V, Custodio, A, Marazuela, M, Segura, A, Beguiristain, A, Llanos, M, Martinez Del Prado MP, Diaz-Perez, JA, Castellano, D, Sevilla, I, Lopez, C, Alonso, T, Garcia-Carbonero, R (2018).
Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE)
ONCOLOGIST. Article. 23(4):422-432.
[doi:10.1634/theoncologist.2017-0364]
Cala, MP, Agullo-Ortuno, MT, Prieto-Garcia, E, Gonzalez-Riano, C, Parrilla-Rubio, L, Barbas, C, Diaz-Garcia, CV, Garcia, A, Pernaut, C, Adeva, J, Riesco, MC, Ruperez, FJ, Lopez-Martin, JA (2018).
Multiplatform plasma fingerprinting in cancer cachexia: a pilot observational and translational study
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE. Article. 9(2):348-357.
[doi:10.1002/jcsm.12270]
Brandariz L, Arriba M, García JL, Cano JM, Rueda D, Rubio E, Rodríguez Y, Pérez J, Vivas A, Sánchez C, Tapial S, Pena L, García-Arranz M, García-Olmo D, Urioste M, González-Sarmiento R, Perea J (2018).
Differential clinicopathological and molecular features within late-onset colorectal cancer according to tumor location.
Oncotarget. Article. 9(20):15302-15311.
[doi:10.18632/oncotarget.24502]
Tabernero, J, Hozak, RR, Yoshino, T, Cohn, AL, Obermannova, R, Bodoky, G, Garcia-Carbonero, R, Ciuleanu, TE, Portnoy, DC, Prausova, J, Muro, K, Siegel, RW, Konrad, RJ, Ouyang, H, Melemed, SA, Ferry, D, Nasroulah, F, Van Cutsem, E (2018).
Analysis of angiogenesis biomarkers for ramucirumab efficacy in patients with metastatic colorectal cancer from RAISE, a global, randomized, double-blind, phase III study
ANNALS OF ONCOLOGY. Article. 29(3):602-609.
[doi:10.1093/annonc/mdx767]
Pavel, M, Gross, DJ, Benavent, M, Perros, P, Srirajaskanthan, R, Warner RRP, Kulke, MH, Anthony, LB, Kunz, PL, Hörsch D, Weickert, MO, Lapuerta, P, Jiang, WJ, Kassler-Taub, K, Wason, S, Fleming, R, Fleming, D, Garcia-Carbonero, R (2018).
Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial
ENDOCRINE-RELATED CANCER. Article. 25(3):309-322.
[doi:10.1530/ERC-17-0455]
Garrido, ML, Morago, AJ, Rovira, PS, Olarte, PE, Sanchez, CP, Sanchez, LM (2018).
Experience with eribulin in the treatment of elderly women with metastatic breast cancer:case studies
FUTURE ONCOLOGY. Article. 14(7):21-27.
[doi:10.2217/fon-2017-0357]
Tapial S, Rueda D, Arriba M, Luis Garcia J, Brandariz L, Perez J, Rodriguez Y, Garcia-Olmo D, Gonzalez-Sarmiento R, Urioste M, Perea J (2018).
Comment on 'Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system'
BRITISH JOURNAL OF CANCER. Letter. 118(3).
[doi:10.1038/bjc.2017.343]
Tabernero, J, Hozak, RR, Yoshino, T, Cohn, AL, Obermannova, R, Bodoky, G, Garcia-Carbonero, R, Ciuleanu, T, Portnoy, D, Muro, K, Ouyang, H, Melemed, SA, Ferry, D, Nasroulah, F, Cutsem, EV (2018).
Analysis of Angiogenesis Biomarkers for Ramucirumab (RAM) Efficacy in Patients with Metastatic Colorectal Cancer (mCRC) from RAISE, a Global, Randomized, Double-blind, Phase 3 Study
ONCOLOGY RESEARCH AND TREATMENT. Meeting Abstract. 41:55-55.
Portnoy, D, Obermannova, R, Bodoky, G, Prausova, J, Garcia-Carbonero, R, Ciuleanu, T, Alfonso, PG, Cohn, AL, Cutsem, EV, Yamazaki, K, Yoshino, T, Lonardi, S, Kim, TW, Yamaguchi, K, Grothey, A, O'Connor, J, Hsu, Y, Ferry, D, Nasroulah, F, Tabernero, J (2018).
Exploratory Analysis of Left Versus Right-sided colorectal Carcinoma in RAISE, a Randomized, Double-blind, Phase 3 Trial of Ramucirumab (RAM) plus FOLFIRI Versus Placebo (PBO) plus FOLFIRI
ONCOLOGY RESEARCH AND TREATMENT. Meeting Abstract. 41:54-54.
Hernando-Cubero, J, Manzano, JL, Benavent, M, Lopez, C, Teule, R, Garcia-Carbonero, R, Carmona-Bayonas, A, Crespo, G, Cubillo, A, Jimenez-Fonseca, P, LaCasta, A, Capdevila, J (2018).
Durvalumab plus Tremelimumab for the Treatment of Patients (pts) with Advanced Neuroendocrine Neoplasms (NENs) of Lung or Gastroenteropancreatic (GEP) Origin. A Phase II Multicohort Trial (DUNE Trial / GETNE 1601)
NEUROENDOCRINOLOGY. Meeting Abstract. 106:228-228.
Carmona-Bayonas, A, Jimenez-Fonseca, P, Castano, A, Capdevila, J, Benavent, M, Custodio, A, Alonso, V, Alonso, T, Del Olmo, MI, Peraita, SL, Teule, A, Garcia-Carbonero, R (2018).
Expanding the WHO 2017 Classification to Gastrointestinal Tumors: Real-World Data from the R-GETNE Registry
NEUROENDOCRINOLOGY. Meeting Abstract. 106:138-138.
Carmona-Bayonas, A, del Valle, A, Solis, MP, Matos, I, Garcia-Carbonero, R, Alonso, V, Custodio, A, Alonso, T, Benavent, M, Viudez, A, Capdevila, J, Jimenez-Fonseca, P (2018).
Prognostic Impact of CHOI Response Criteria Compared to RECIST in Grade 1-2 Advanced Pancreatic Neuroendocrine Tumors (CRIPNET-GETNE Study-NCT02841865)
NEUROENDOCRINOLOGY. Meeting Abstract. 106:169-169.
Jimenez-Fonseca, P, Hernandez, MPS, Del Valle, AF, Garcia-Carbonero, R, Matos, I, Alonso, V, Custodio, A, Alonso, T, Canovas, MS, Benavent, M, Lopez, C, Carmona-Bayonas, A (2018).
Efficacy of Sunitinib Correlated with Clinical, Radiological Variables, Dose-Intensity and Treatment Time in Advanced Grade 1-2 Pancreatic Neuroendocrine Tumors (CRIPNET-GETNE Study NCT02841865)
NEUROENDOCRINOLOGY. Meeting Abstract. 106:214-214.
Borbath, I, Pape, UF, Garcia-Carbonero, R, Sedlackova, E, Kollar, A, Kos-Kudla, B, Jimenez-Fonseca, P, Barkmanova, J, Maasberg, S, Bikmukhametov, D, Kaltsas, G, Verslype, C (2018).
The ENETS Registry: First Results of a Collaborative Effort Including over 12.000 Patients with Neuroendocrine Neoplasms (NENs) from 7 European Countries
NEUROENDOCRINOLOGY. Meeting Abstract. 106:62-62.
Bellido, F, Sowada, N, Mur, P, Lazaro, C, Pons, T, Valdes-Mas, R, Pineda, M, Aiza, G, Iglesias, S, Soto, JL, Urioste, M, Caldes, T, Balbin, M, Blay, P, Rueda, D, Duran, M, Valencia, A, Moreno, V, Brunet, J, Blanco, I, Navarro, M, Calin, GA, Borck, G, Puente, XS, Capella, G, Valle, L (2018).
Association Between Germline Mutations in &ITBRF1&IT, a Subunit of the RNA Polymerase III Transcription Complex, and Hereditary Colorectal Cancer
GASTROENTEROLOGY. Article. 154(1):181.
[doi:10.1053/j.gastro.2017.09.005]
Siena, S, Sartore-Bianchi, A, Garcia-Carbonero, R, Karthaus, M, Smith, D, Tabernero, J, Van Cutsem, E, Guan, X, Boedigheimer, M, Ang, A, Twomey, B, Bach, BA, Jung, AS, Bardelli, A (2018).
Dynamic molecular analysis and clinical correlates of tumor evolution within a phase II trial of panitumumab-based therapy in metastatic colorectal cancer
ANNALS OF ONCOLOGY. Article. 29(1):119-126.
[doi:10.1093/annonc/mdx504]
Alonso, N, Cañueto J, Ciria, S, Bueno, E, Palacios-Alvarez, I, Alegre, M, Badenas, C, Barreiro, A, Pena, L, Maldonado, C, Nespeira-Jato, MV, Peña-Penabad C, Azon, A, Gavrilova, M, Ferrer, I, Sanmartin, O, Robles, L, Hernandez-Martin, A, Urioste, M, Puig, S, Puig, L, Gonzalez-Sarmiento, R (2018).
Novel clinical and molecular findings in Spanish patients with naevoid basal cell carcinoma syndrome
BRITISH JOURNAL OF DERMATOLOGY. Article. 178(1):198-206.
[doi:10.1111/bjd.15835]
Zugazagoitia, J, Rueda, D, Carrizo, N, Enguita, AB, Gomez-Sanchez, D, Diaz-Serrano, A, Jimenez, E, Merida, A, Calero, R, Lujan, R, De Miguel, E, Gamez, P, Diaz-Hellin, V, Nuñez JA, Iglesias, L, Ferrer, I, Paz-Ares, L, Ponce-Aix, S (2018).
Prospective Clinical Integration of an Amplicon-Based Next-Generation Sequencing Method to Select Advanced Non-Small-Cell Lung Cancer Patients for Genotype-Tailored Treatments
CLINICAL LUNG CANCER. Article. 19(1):65.
[doi:10.1016/j.cllc.2017.06.008]
Capdevila, J, Mancuso, F, Landolfi, S, Martinez-Cardus, A, Barriuso, J, Lopez, C, Grande, E, Miguel, C, Garcia-Carbonero, R, Hernando, J, Vivancos, A, Garcia-Palmer, H (2018).
BRAF-V600E Driven Mutations in Grade 3 Neuroendocrine Carcinomas of Colon Origin: Results from Genomic/Epigenomic Profilings and Patient-Derived Mouse Model
NEUROENDOCRINOLOGY. Meeting Abstract. 106:25-25.
Muñoz Martín AJ, Adeva J, Martínez-Galán J, Reina JJ, Hidalgo M (2017).
Pancreatic ductal adenocarcinoma: metastatic disease
CLINICAL & TRANSLATIONAL ONCOLOGY. Review. 19(12):1423-1429.
[doi:10.1007/s12094-017-1690-6]
Ovarian Tumor Tissue Analysis (OTTA) Consortium, Goode EL, Block MS, Kalli KR, Vierkant RA, Chen W, Fogarty ZC, Gentry-Maharaj A, Toloczko A, Hein A, Bouligny AL, Jensen A, Osorio A, Hartkopf AD, Ryan A, Chudecka-Glaz A, Magliocco AM, Hartmann A, Jung AY, Gao B, Hernandez BY, Fridley BL, McCauley BM, Kennedy CJ, Wang C, Karpinskyj C, de Sousa CB, Tiezzi DG, Wachter DL, Herpel E, Taran FA, Modugno F, Nelson G, Lubinski J, Menkiszak J, Alsop J, Lester J, García-Donas J, Nation J, Hung J, Palacios J, Rothstein JH, Kelley JL, de Andrade JM, Robles-Díaz L, Intermaggio MP, Widschwendter M, Beckmann MW, Ruebner M, Jimenez-Linan M, Singh N, Oszurek O, Harnett PR, Rambau PF, Sinn P, Wagner P, Ghatage P, Sharma R, Edwards RP, Ness RB, Orsulic S, Brucker SY, Johnatty SE, Longacre TA, Eilber U, McGuire V, Sieh W, Natanzon Y, Li Z, Whittemore AS, deFazio A, Staebler A, Karlan BY, Gilks B, Bowtell DD, Høgdall E, Candido Dos Reis FJ, Steed H, Campbell IG, Gronwald J, Benítez J, Koziak JM, Chang-Claude J, Moysich KB, Kelemen LE, Cook LS, Goodman MT, García MJ, Fasching PA, Kommoss S, Deen S, Kjaer SK, Menon U, Brenton JD, Pharoah PDP, Chenevix-Trench G, Huntsman DG, Winham SJ, Köbel M, Ramus SJ (2017).
Dose-Response Association of CD8(+) Tumor-Infiltrating Lymphocytes and; Survival Time in High-Grade Serous Ovarian Cancer
JAMA oncology. Article. 3(12).
[doi:10.1001/jamaoncol.2017.3290]
Van Cutsem E, Falcone A, Garcia-Carbonero R, Komatsu Y, Pastorino A, Peeters M, Shimada Y, Yamazaki K, Yoshino T, Zaniboni A, Amellal N, Kanehisa A, Winkler R, Makris L, Mayer RJ, Ohtsu A, Tabernero J (2017).
Proxies of quality of life in metastatic colorectal cancer: analyses in the RECOURSE trial.
Esmo Open. Article. 2(5).
[doi:10.1136/esmoopen-2017-000261]
Lorca V, Rueda D, Martín-Morales L, Poves C, Fernández-Aceñero MJ, Ruiz-Ponte C, Llovet P, Marrupe D, García-Barberán V, García-Paredes B, Pérez-Segura P, de la Hoya M, Díaz-Rubio E, Caldés T, Garre P (2017).
Role of GALNT12 in the genetic predisposition to attenuated adenomatous; polyposis syndrome
PLOS ONE. Article. 12(11).
[doi:10.1371/journal.pone.0187312]
Riesco-Martinez MC, Sanchez-Torre A, Garcia-Carbonero R (2017).
Safety and efficacy of nintedanib for the treatment of metastatic; colorectal cancer
EXPERT OPINION ON INVESTIGATIONAL DRUGS. Article. 26(11):1295-1305.
[doi:10.1080/13543784.2017.1385762]
Garcia-Carbonero R, Salazar R, Duran I, Osman-Garcia I, Paz-Ares L, Bozada JM, Boni V, Blanc C, Seymour L, Beadle J, Alvis S, Champion B, Calvo E, Fisher K (2017).
Phase 1 study of intravenous administration of the chimeric adenovirus; enadenotucirev in patients undergoing primary tumor resection
Journal For Immunotherapy Of Cancer. Article. 5(1):71-71.
[doi:10.1186/s40425-017-0277-7]
Carmona-Bayonas, A, Jimenez-Fonseca, P, Custodio, A, Grande, E, Capdevila, J, Lopez, C, Teule, A, Garcia-Carbonero, R, Spanish Neuroendocrine Tumor (2017).
Optimizing Somatostatin Analog Use in Well or Moderately Differentiated; Gastroenteropancreatic Neuroendocrine Tumors
Current Oncology Reports. Review. 19(11):72-72.
[doi:10.1007/s11912-017-0633-2]
Cohn AL, Yoshino T, Heinemann V, Obermannova R, Bodoky G, Prausová J, Garcia-Carbonero R, Ciuleanu T, Garcia-Alfonso P, Portnoy DC, Van Cutsem E, Yamazaki K, Clingan PR, Polikoff J, Lonardi S, O'Brien LM, Gao L, Yang L, Ferry D, Nasroulah F, Tabernero J (2017).
Exposure-response relationship of ramucirumab in patients with advanced second-line colorectal cancer: exploratory analysis of the RAISE trial
CANCER CHEMOTHERAPY AND PHARMACOLOGY. Article. 80(3):599-608.
[doi:10.1007/s00280-017-3380-z]
Santos C, Azuara D, Garcia-Carbonero R, Alfonso PG, Carrato A, Elez ME, Gomez A, Losa F, Montagut C, Massuti B, Navarro V, Varela M, Lopez-Doriga A, Moreno V, Valladares M, Manzano JL, Vieitez JM, Aranda E, Sanjuan X, Tabernero J, Capella G, Salazar R (2017).
Optimization of RAS/BRAF Mutational Analysis Confirms Improvement in; Patient Selection for Clinical Benefit to Anti-EGFR Treatment in; Metastatic Colorectal Cancer
MOLECULAR CANCER THERAPEUTICS. Article. 16(9):1999-2007.
[doi:10.1158/1535-7163.MCT-17-0153]
Perez JM, Lopez-Calderero I, Saez C, Benavent M, Limon ML, Gonzalez-Exposito R, Soldevilla B, Riesco-Martinez MC, Salamanca J, Carnero A, Garcia-Carbonero R (2017).
Prognostic relevance of Src activation in stage II-III colon cancer
HUMAN PATHOLOGY. Article. 67:119-125.
[doi:10.1016/j.humpath.2017.05.025]
Riesco-Martinez M, Parra K, Saluja R, Francia G, Emmenegger U (2017).
Resistance to metronomic chemotherapy and ways to overcome it
CANCER LETTERS. Review. 400:311-318.
[doi:10.1016/j.canlet.2017.02.027]
Pellicer M, García-González X, García MI, Blanco C, García-Alfonso P, Robles L, Grávalos C, Rueda D, Martínez J, Pachón V, Longo F, Martínez V, Iglesias I, Salvador S, Sanjurjo M, López-Fernández LA (2017).
Use of exome sequencing to determine the full profile of genetic; variants in the fluoropyrimidine pathway in colorectal cancer patients; affected by severe toxicity
Pharmacogenomics. Article. 18(13):1215-1223.
[doi:10.2217/pgs-2017-0118]
Yuste C, Mérida E, Hernández E, García-Santiago A, Rodríguez Y, Muñoz T, Gómez GJ, Sevillano Á, Praga M (2017).
Gastrointestinal complications induced by sevelamer crystals
CLINICAL KIDNEY JOURNAL. Article. 10(4):539-544.
[doi:10.1093/ckj/sfx013]
Custodio A, Carmona-Bayonas A, Jiménez-Fonseca P, Sánchez ML, Viudez A, Hernández R, Cano JM, Echavarria I, Pericay C, Mangas M, Visa L, Buxo E, García T, Rodríguez Palomo A, Álvarez Manceñido F, Lacalle A, Macias I, Azkarate A, Ramchandani A, Fernández Montes A, López C, Longo F, Sánchez Bayona R, Limón ML, Díaz-Serrano A, Hurtado A, Madero R, Gómez C, Gallego J (2017).
Nomogram-based prediction of survival in patients with advanced; oesophagogastric adenocarcinoma receiving first-line chemotherapy: a; multicenter prospective study in the era of trastuzumab
BRITISH JOURNAL OF CANCER. Article. 116(12):1526-1535.
[doi:10.1038/bjc.2017.122]
Soldevilla B, CUEVAS MARTIN, MARIA DEL CARMEN, Ibáñez C, Santacatterina F, Alberti MA, Simó C, Casasnovas C, Márquez-Infante C, Sevilla T, Pascual SI, Sánchez-Aragó M, Espinos C, Palau F, Cuezva JM (2017).
Plasma metabolome and skin proteins in Charcot-Marie-Tooth 1A patients
PLOS ONE. Article. 12(6).
[doi:10.1371/journal.pone.0178376]
Yoshino T, Obermannová R, Bodoky G, Garcia-Carbonero R, Ciuleanu T, Portnoy DC, Kim TW, Hsu Y, Ferry D, Nasroulah F, Tabernero J (2017).
Baseline carcinoembryonic antigen as a predictive factor of ramucirumab; efficacy in RAISE, a second-line metastatic colorectal carcinoma phase; III trial
EUROPEAN JOURNAL OF CANCER. Article. 78:61-69.
[doi:10.1016/j.ejca.2017.03.007]
Pellicer M, García-González X, García MI, Robles L, Grávalos C, García-Alfonso P, Pachón V, Longo F, Martínez V, Blanco C, Iglesias I, Sanjurjo M, López-Fernández LA (2017).
Identification of new SNPs associated with severe toxicity to; capecitabine
PHARMACOLOGICAL RESEARCH. Article. 120:133-137.
[doi:10.1016/j.phrs.2017.03.021]
Hidalgo, M, Alvarez, R, Gallego, J, Guillen-Ponce, C, Laquente, B, Macarulla, T, Munoz, A, Salgado, M, Vera, R, Adeva, J, Ales, I, Arevalo, S, Blazquez, J, Calsina, A, Carmona, A, de Madaria, E, Diaz, R, Diez, L, Fernandez, T, de Paredes, BG, Gallardo, ME, Gonzalez, I, Hernando, O, Jimenez, P, Lopez, A, Lopez, C, Lopez-Rios, F, Martin, E, Martinez, J, Martinez, A, Montans, J, Pazo, R, Plaza, JC, Peiro, I, Reina, JJ, Sanjuanbenito, A, Yaya, R, Carrato, A (2017).
Consensus guidelines for diagnosis, treatment and follow-up of patients; with pancreatic cancer in Spain
CLINICAL & TRANSLATIONAL ONCOLOGY. Article. 19(6):667-681.
[doi:10.1007/s12094-016-1594-x]
Lamarca A, Walter T, Pavel M, Borbath I, Freis P, Nuñez B, Childs A, McNamara MG, Hubner RA, Garcia-Carbonero R, Meyer T, Valle JW, Barriuso J (2017).
Design and Validation of the GI-NEC Score to Prognosticate Overall; Survival in Patients With High-Grade Gastrointestinal Neuroendocrine; Carcinomas
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. Article. 109(5).
[doi:10.1093/jnci/djw277]
Perea J, García JL, Pérez J, Rueda D, Arriba M, Rodríguez Y, Urioste M, González-Sarmiento R (2017).
NOMO-1 gene is deleted in early-onset colorectal cancer
Oncotarget. Article. 8(15):24429-24436.
[doi:10.18632/oncotarget.15478]
García-Ledo L, Nuevo-Tapioles C, CUEVAS MARTIN, MARIA DEL CARMEN, Martínez-Reyes I, Soldevilla B, González-Llorente L, Cuezva JM (2017).
Overexpression of the ATPase Inhibitory Factor 1 Favors a Non-metastatic; Phenotype in Breast Cancer
Frontiers in oncology. Article. 7:69-69.
[doi:10.3389/fonc.2017.00069]
Oberg K, Couvelard A, Delle Fave G, Gross D, Grossman A, Jensen RT, Pape UF, Perren A, Rindi G, Ruszniewski P, Scoazec JY, Welin S, Wiedenmann B, Ferone D, Antibes Consensus Conference participants (2017).
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical Markers
NEUROENDOCRINOLOGY. Article. 105(3):201-211.
[doi:10.1159/000472254]
Garcia-Carbonero R, Rinke A, Valle JW, Fazio N, Caplin M, Gorbounova V, O''Connor J, Eriksson B, Sorbye H, Kulke M, Chen J, Falkerby J, Costa F, de Herder W, Lombard-Bohas C, Pavel M, all other Antibes Consensus Conference participants (2017).
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine; Neoplasms: Systemic Therapy - Chemotherapy
NEUROENDOCRINOLOGY. Article. 105(3):281-294.
[doi:10.1159/000473892]
García-Carbonero R, van Cutsem E, Rivera F, Jassem J, Gore I, Tebbutt N, Braiteh F, Argiles G, Wainberg ZA, Funke R, Anderson M, McCall B, Stroh M, Wakshull E, Hegde P, Ye W, Chen D, Chang I, Rhee I, Hurwitz H (2017).
Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in; Combination with FOLFOX and Bevacizumab for First-Line Metastatic; Colorectal Cancer
ONCOLOGIST. Article. 22(4):375-30.
[doi:10.1634/theoncologist.2016-0133]
Salvador J, Aparicio J, Baron FJ, García-Campelo R, Garcia-Carbonero R, Lianes P, Llombart A, Isla D, Piera JM, Muñoz M, Puente J, Rivera F, Rodríguez CA, Virizuela JA, Martín M, Garrido P (2017).
Equity, barriers and cancer disparities: study of the Spanish Society of; Medical Oncology on the access to oncologic drugs in the Spanish Regions; (vol 19, pg 341, 2017)
CLINICAL & TRANSLATIONAL ONCOLOGY. Correction. 19(4):525-525.
[doi:10.1007/s12094-017-1628-z]
Sundin A, Arnold R, Baudin E, Cwikla JB, Eriksson B, Fanti S, Fazio N, Giammarile F, Hicks RJ, Kjaer A, Krenning E, Kwekkeboom D, Lombard-Bohas C, O'Connor JM, O'Toole D, Rockall A, Wiedenmann B, Valle JW, Vullierme MP, Antibes Consensus Conference participants (2017).
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging
NEUROENDOCRINOLOGY. Article. 105(3):212-244.
[doi:10.1159/000471879]
Perea J, Arriba M, Rodríguez Y, Rueda D, García JL, Pérez J, González-Sarmiento R, Urioste M (2017).
Frequency and impact of KRAS mutation in early onset colorectal cancer
HUMAN PATHOLOGY. Letter. 61:221-222.
[doi:10.1016/j.humpath.2016.07.039]
Michael M, Garcia-Carbonero R, Weber MM, Lombard-Bohas C, Toumpanakis C, Hicks RJ (2017).
The Antiproliferative Role of Lanreotide in Controlling Growth of; Neuroendocrine Tumors: A Systematic Review
ONCOLOGIST. Review. 22(3):272-285.
[doi:10.1634/theoncologist.2016-0305]
Arriba, Maria, Sanchez, Ricardo, Rueda, Daniel, Gomez, Laura, Garcia, Juan L., Rodriguez, Yolanda, Antonio Pajares, Jose, Perez, Jessica, Urioste, Miguel, Gonzalez Sarmiento, Rogelio, Perea, Jose (2017).
Toward a Molecular Classification of Synchronous Colorectal Cancer:; Clinical and Molecular Characterization
Clinical Colorectal Cancer. Article. 16(1):31-37.
[doi:10.1016/j.clcc.2016.07.014]
Pavel, Marianne, Gross, David, Benavent, Marta, Caplin, Martyn, Perros, Petros, Srirajaskanthan, Raj, Valle, Juan, Warner, Richard, Kulke, Matthew, Anthony, Lowell, Kunz, Pamela, Hoersch, Dieter, Oberg, Kjell, Lapuerta, Pablo, Jackson, Shanna, Banks, Phillip, Biran, Talia, Garcia-Carbonero, Rocio (2017).
Efficacy and Safety Results of Telotristat Ethyl in Patients With Carcinoid Syndrome During the Double-blind Treatment Period of the TELECAST Phase 3 Clinical Trial
Pancreas. Meeting Abstract. 46(3):434-435.
Partelli S, Bartsch DK, Capdevila J, Chen J, Knigge U, Niederle B, Nieveen van Dijkum EJM, Pape UF, Pascher A, Ramage J, Reed N, Ruszniewski P, Scoazec JY, Toumpanakis C, Kianmanesh R, Falconi M, Antibes Consensus Conference participants (2017).
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours
NEUROENDOCRINOLOGY. Article. 105(3):255-265.
[doi:10.1159/000464292]
Knigge U, Capdevila J, Bartsch DK, Baudin E, Falkerby J, Kianmanesh R, Kos-Kudla B, Niederle B, Nieveen van Dijkum E, O'Toole D, Pascher A, Reed N, Sundin A, Vullierme MP, Antibes Consensus Conference Participants, Antibes Consensus Conference participants (2017).
ENETS Consensus Recommendations for the Standards of Care in Neuroendocrine Neoplasms: Follow-Up and Documentation
NEUROENDOCRINOLOGY. Article. 105(3):310-319.
[doi:10.1159/000458155]
Perren A, Couvelard A, Scoazec JY, Costa F, Borbath I, Delle Fave G, Gorbounova V, Gross D, Grossma A, Jense RT, Kulke M, Oeberg K, Rindi G, Sorbye H, Welin S, Antibes Consensus Conference participants (2017).
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology-Diagnosis and Prognostic Stratification
NEUROENDOCRINOLOGY. Article. 105(3):196-200.
[doi:10.1159/000457956]
Garcia-Carbonero, R., Vera, R., Rivera, F., Parlorio, E., Pages, M., Gonzalez-Flores, E., Fernandez-Martos, C., Corral, M. A., Bouzas, R., Matute, F. (2017).
SEOM/SERAM consensus statement on radiological diagnosis, response; assessment and follow-up in colorectal cancer
CLINICAL & TRANSLATIONAL ONCOLOGY. Article. 19(2):135-148.
[doi:10.1007/s12094-016-1518-9]
Arriba, M, Garcia, JL, Rueda, D, Perez, J, Brandariz, L, Nutu, OA, Alonso, L, Rodriguez, Y, Urioste, M, Gonzalez-Sarmiento, R, Perea, J (2017).
Unsupervised Analysis of Array Comparative Genomic Hybridization Data; from Early-Onset Colorectal Cancer Reveals Equivalence with Molecular; Classification and Phenotypes
NEOPLASIA. Article. 19(1):28-34.
[doi:10.1016/j.neo.2016.11.006]
Kaltsas, G, Caplin, M, Davies, P, Ferone, D, Garcia-Carbonero, R, Grozinsky-Glasberg, S, Horsch, D, Janson, ET, Kianmanesh, R, Kos-Kudla, B, Pavel, M, Rinke, A, Falconi, M, de Herder, WW, All Other Antibes Consensus Conf (2017).
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine; Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine; Tumors
NEUROENDOCRINOLOGY. Article. 105(3):245-254.
[doi:10.1159/000461583]
Pavel, M, Valle, JW, Eriksson, B, Rinke, A, Caplin, M, Chen, J, Costa, F, Falkerby, J, Fazio, N, Gorbounova, V, de Herder, W, Kulke, M, Lombard-Bohas, C, O'Connor, J, Sorbye, H, Garcia-Carbonero, R, All Other Antibes Consensus Conf (2017).
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine; Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents
NEUROENDOCRINOLOGY. Article. 105(3):266-280.
[doi:10.1159/000471880]
Barrios, MP, Martin, RL, Peerez, SP, Tamariz, VV, Yolanda, R, de Miguel, RA, Algarra, AC, de la Cruz, EG, Romero, PO, Peralto, JR (2017).
Phacomatosis Pigmentokeratotica: Mosaic RASopathies as a key to better; understand cancer
JOURNAL OF INVESTIGATIVE DERMATOLOGY. Meeting Abstract. 137(10):229-229.
[doi:10.1016/j.jid.2017.07.214]
Capdevila, J, Mancuso, F, Landolfi, S, Salva, F, Miguel, C, Jimenez-Fonseca, P, Garcia-Carbonero, R, Lopez, CL, Casteras, A, Nadal, TS, Nuciforo, P, Vivancos, A, Matos, I (2017).
Different RNA expression profile defines prognosis in grade 1/2; neuroendocrine neoplasms of small intestine origin: The GETNE-NETSEQ; study
ANNALS OF ONCOLOGY. Meeting Abstract. 28.
Fernandez, A, Salgado, M, Garcia, A, Buxo, E, Vera, R, Adeva, J, Jimenez, P, Quintero, G, Llorca, C, Canabate, M, Lopez, LJ, Munoz, A, Ramirez, P, Gonzalez, P, Lopez, C, Reboredo, M, Gallardo, E, Sanchez, M, Gallego, J, Guillen, C (2017).
Treatment patterns, clinical characteristics, and outcomes of patients; (pts) with metastatic pancreatic cancer (MPC) treated with; nab-paclitaxel (nab-P) plus gemcitabine (GEM) in real-life practice:; ANICE-Pac trial
ANNALS OF ONCOLOGY. Meeting Abstract. 28.
Pulido, EG, Teule, A, Alonso-Gordoa, T, Jimenez-Fonseca, P, Benavent, M, Capdevila, J, Custodio, A, Vera, R, Munarriz, J, La Casta-Munoa, A, Garcia-Carbonero, R (2017).
A phase II trial of palbociclib in metastatic grade 1/2 pancreatic; neuroendocrine tumors: The PALBONET study on behalf of the Spanish; Taskforce Group of Neuroendocrine Tumors (GETNE)
ANNALS OF ONCOLOGY. Meeting Abstract. 28.
Lopez-Martin, JA, Cala, M, Prieto-Garcia, E, Riano, CG, Diaz-Garcia, CV, Garcia, A, Marques, VP, Pascualena, FR, Garcia-Ruiz, I, Pernaut, C, Otero, I, Rubio, LP, Riesco, MC, Alfonso, JA, Barbas, C, Agullo-Ortuno, MT (2017).
Metabolomics in cancer cachexia
ANNALS OF ONCOLOGY. Meeting Abstract. 28.
De Mingo, ML, Guadalix, S, Alvarez, MBL, Herrero, EF, Diaz-Guerra, GM, Hawkins, F (2017).
Longer duration of TSH suppression can affect Bone Mineral Density and; Trabecular Bone Score in patients with Differentiated Thyroid Cancer.
JOURNAL OF BONE AND MINERAL RESEARCH. Meeting Abstract. 32:263-264.
German-Diaz, M, Rodriguez-Gil, Y, Cruz-Rojo, J, Charbit-Henrion, F, Cerf-Bensussan, N, Manzanares-Lopez Manzanares, J, Moreno-Villares, JM (2017).
A New Case of Congenital Malabsorptive Diarrhea and Diabetes Secondary; to Mutant Neurogenin-3
PEDIATRICS. Article. 140(2).
[doi:10.1542/peds.2016-2210]
Garcia-Carbonero, Rocio, van Cutsem, Eric, Rivera, Fernando, Jassem, Jacek, Gore, Jr., Ira, Tebbutt, Niall, Braiteh, Fadi, Argiles, Guillem, Wainberg, Zev A., Funke, Roel, Anderson, Maria, McCall, Bruce, Stroh, Mark, Wakshull, Eric, Hegde, Priti, Ye, Weilan, Chen, Daniel, Chang, Ilsung, Rhee, Ina, Hurwitz, Herbert (2017).
Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First-Line Metastatic Colorectal Cancer (vol 22, pg 375, 2017)
ONCOLOGIST. Correction. 22(10):1281-1281.
[doi:10.1634/theoncologist.2016-0133erratum]
